Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2007 www.aodhealth.org Featured Article Risk factors for clinically recognized opioid abuse and dependence among veterans using.
Download ReportTranscript Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2007 www.aodhealth.org Featured Article Risk factors for clinically recognized opioid abuse and dependence among veterans using.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2007 www.aodhealth.org 1 Featured Article Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain Edlund MJ, et al. Pain. 2007;129(3):355–362. www.aodhealth.org 2 Study Objective To identify… • risk factors for diagnosed opioid abuse or dependence among chronic opioid users www.aodhealth.org 3 Study Design • Researchers analyzed demographic and clinical data from 15,160 veterans with… – chronic opioid use (>90 day prescription) for noncancer pain but – no diagnosis of an opioid use disorder (opioid abuse or dependence) in their medical records in 2000–2002. • Researchers then compared veterans with a subsequent diagnosis of an opioid use disorder in 2003–2005 with veterans without this diagnosis in the same period. www.aodhealth.org 4 Assessing Validity of an Article About Harm • Are the results valid? • What are the results? • How can I apply the results to patient care? www.aodhealth.org 5 Are the Results Valid? • Did the investigators demonstrate similarity in all known determinants of outcomes? Did they adjust for differences in the analysis? • Were exposed patients equally likely to be identified in the two groups? • Were the outcomes measured in the same way in the groups being compared? • Was follow-up sufficiently complete? www.aodhealth.org 6 Did the investigators demonstrate similarity in all known determinants of outcomes? Did they adjust for differences in the analysis? • All subjects were prescribed opioids. • Factors known to be associated with developing prescription drug dependence (substance use disorders and psychiatric comorbidity) were controlled for in the mulitvariable analyses. • Multivariable analyses did not adjust for the type of opioid (short vs. long-acting, weak vs. potent) that was prescribed. www.aodhealth.org 7 Were exposed patients equally likely to be identified in the two groups? All patients were prescribed opioids. www.aodhealth.org 8 Were the outcomes measured in the same way in the groups being compared? Passive surveillance was conducted for ICD-9 diagnoses of opioid abuse or dependence. There was no attempt to systematically assess patients for opioid abuse or dependence. www.aodhealth.org 9 Was follow-up sufficiently complete? • Follow-up was obtained on all individuals in the cohort at 1–3 years. • This may not be sufficient time for a diagnosis of opioid abuse or dependence to be recognized. www.aodhealth.org 10 What are the Results? • How strong is the association between exposure and outcomes? • How precise is the estimate of the risk? www.aodhealth.org 11 What are the Results? • From 2000-2002 to 2003-2005, 2% were diagnosed with opioid abuse or dependence. • In adjusted analyses, veterans with the following in 2002 were more likely to have a subsequent opioid abuse or dependence diagnosis: – nonopioid substance use disorder (OR, 2.34) – mental health disorder (OR, 1.46) – greater number of outpatient healthcare visits (OR, 1.52 for 20+ visits versus 0–6 visits) – greater number of days supplied with opioids (OR, 1.84 for 211+ days versus 91–150 days) www.aodhealth.org 12 How strong is the association between exposure and outcome? Variable Adjusted Odds Ratios and 95% Confidence Intervals Nonopioid abuse or dependence 2.34 (1.75-3.14) Mental health disorder 1.46 (1.12-1.91) Greater # of outpatient visits 1.52 (1.03-2.25) Greater # of days supplied with opioids 1.84 (1.35-2.51) www.aodhealth.org 13 How precise is the estimate of the risk? • The sample size is large. • The confidence intervals are reasonable. www.aodhealth.org 14 How Can I Apply the Results to Patient Care? • Were the study patients similar to the patients in my practice? • Was the duration of follow-up adequate? • What was the magnitude of the risk? • Should I attempt to stop the exposure? www.aodhealth.org 15 Were the study patients similar to the patients in my practice? • • • • • • • 95% were male. 80% were ≥50 years old. All were veterans. 71% were white. 54% had back pain. 45% had a mental health diagnosis. 47% received >211 days of opioids in the first treatment year. www.aodhealth.org 16 Was the duration of follow-up adequate? • No: – 1–3 years is a short period of time for an individual’s opioid abuse or dependence to come to clinical recognition. www.aodhealth.org 17 What was the magnitude of the risk? • 2% (298 patients) of the sample had their chronic substance use disorder clinically recognized (diagnosis in medical record). www.aodhealth.org 18 Should I attempt to stop the exposure? • No information is presented on the benefit of the opioid therapy that was prescribed. • According to this study, clinicians should assess the benefit of opioid therapy against the potential risk for opioid abuse and dependence… – especially in patients with prior diagnoses of substance use disorders, mental health disorders, high volume of clinic visits, and long-term opioid prescriptions. www.aodhealth.org 19